Nanomedicine

Welcome to The Department of Nanomedicine

The Department of Nanomedicine at The Methodist Hospital Research Institute in Houston, TX is co-directed by Drs. Alessandro Grattoni, Jason Sakamoto, Rita Serda, and Ennio Tasciotti. The Department focuses on inter-disciplinary research to combine nano-engineering, mathematical modeling and biomedical sciences to develop nanotechnology enabled therapeutic and diagnostic platforms for combating diseases including cancer, cardiovascular diseases and infectious diseases.

Our ongoing research projects include:

• Injectable NanoVectors for Directed (Targeted/personalized) Therapeutics
• Intelligent Implants for Controlled Time Release of Therapy
• BioNanoScaffolds for Post-Traumatic OsteoRegeneration
• Early Detection of Disease from Blood Proteomic Signatures

More on research...

Selected Publications

V Gewin (2009).
Big opportunities in a small world
Nature 460(23): 540-541.

M Ferrari (2009).
Straight talk with... Mauro Ferrari
Nature Medicine 15(7): 716-717.

M Ferrari, MA Philibert, WR Sanhai (2009).
Nanomedicine and Society
Clinical Pharmacology and Therapeutics 85(5): 466-467.

J Evans (2009).
Five big ideas for nanotechnology
Nature Medicine 15(4): 348.

M Ferrari (2008).
Nanogeometry: Beyond Drug Delivery
Nature Nanotechnology 3(3):131-132.

W Sanhai, J Sakamoto, R Canady and M Ferrari (2008).
Seven Challenges for Nanomedicine
Nature Nanotechnology 3(5):242-244.

Mesoporous Silicon Particles as a Multistage Delivery System for Imaging and Therapeutic Applications
Nature Nanotechnology 3(3):151-157.

M Ferrari (2006).
nan'o tech nol'o gy n.
Nature Nanotechnology 1:8-10.

M Ferrari (2005).
Cancer nanotechnology: opportunities and challenges
Nature Reviews Cancer 5:161-171.

L Liotta, M Ferrari and E Petricoin (2003).
Clinical proteomics: Written in blood
Nature 425:905.